Jose Riquelme is 73 years old and has been retired for 11 years. they were diagnosed diabetes Type 2 shortly after quitting his job as an engineer. He is one of the diabetic patients who have been seen Affected by the ‘boom’ of OzampicNovo Nordisk is based on the drug semaglutide which many influential people They have become fashionable because of their effect on weight loss and have been in short supply in Spanish pharmacies since October last year.
Although according to the Spanish Agency for Medicines and Health Products (Emps) the Ozempic supply problem has already been resolved, the reality is that pharmacies continue to receive it “drop by drop”, as he explained. 20 minutes From the Spanish Federation of Spanish Pharmacists (FEDE).
One of the patients left without his treatment was Riquelme, who during “Three weeks” Last December he had to resort to one of the therapeutic options proposed by the health authorities with drugs from the same group. In his case, he was prescribed Rebelsus, which is also semaglutide, but administered Orally (Ozempic enters preformed injection Therefore its administration is subcutaneous) once a day.
The Murcian resident of Alcantarailla highlights among the shortcomings of the changing treatment that the dose of semaglutide will be increased. while ozempic takes 1 mg a weekRebelsus had to take 14 mg a day, “It was crazy if with one milligram a week I go like silk,” he worries about the adverse effects of increased dosage. “I thought I was going to load my kidneys. The difference was terrifying,” he adds over the phone.
Riquelme, who is a member of the Murcian Association for Diabetes Care (Edirmu), has been taking Ozempic for five years, but when he had to temporarily switch to Rebelsus due to a lack of supply of the former, he thought: “I’m going to kill myself”, “I can imagine the difficulties that people over 80 will have when their medication is changed.” A person affected by Ozempic’s deficiency remembers that the disease he suffers from is “for life”, so “you cannot change your medicine every two to three”.
When asked about the side effects that switching from Ozempic to ribuless could cause in patients with type 2 diabetes, Ana de Hollanda, coordinator of the obesity sector of the Spanish Society of Endocrinology and Nutrition (SEEN), revealed 20 minutes that they are “equal therapeutic options that can maintain adequate metabolic control in patients with diabetes.” In fact, he maintains that the adverse effects of ribulus are “less marked, less intense” than those of Ozempic’s subcutaneous semaglutide. “The main difference between the two is that with Ozempic you can lose more weight. Changing medication does not cause any other side effects or discomfort“, he concluded.
To make sure he never runs out of his medicine again, demand for which has soared after its weight-loss effects went viral, José Riquelme orders it at his “lifelong” pharmacy, Reyes Menarguez Apothecary, Alcantarailla . From there they confirm to this newspaper that Ozampic’s supply problems started last October. In November he got four of the 0.5 mg; in December, six; In January he has received “nothing from any presentation”.,
“Demand has increased because people use slim down, You also need a prescription, but they come with prescription from private doctor“, explains the pharmacist. “When they arrive, we call the customers who ordered it from us in order of the order date,” he says.
In its note dated October 18, the amps urged medical personnel priority prescriptions of Ozempic “according to the authorized conditions”, i.e. glycemic control of patients with type 2 diabetes. However, it cited other drugs available from the same therapeutic group, for which it was recommended to resort to if the supply problem persists. Among them, in addition to Rebelsus, are Byetta, Lyxumia, and Victoza.